TY  - RPRT
TI  - The combination of BCL-xL PROTAC and mTOR inhibitor sensitizes pancreatic ductal adenocarcinoma to KRASG12D inhibitor treatment by enhancing apoptosis induction
AU  - Miyan, J.
AU  - Vudatha, V.
AU  - Cao, L.
AU  - Zhang, P.
AU  - Zheng, G.
AU  - Zheng, L.
AU  - Trevino, J.
AU  - Zhou, D.
AU  - KHAN, S.
PY  - 2026
DO  - 10.64898/2026.01.05.697773
UR  - https://www.biorxiv.org/content/10.64898/2026.01.05.697773v1
ID  - 10.64898/2026.01.05.697773
ER  -